Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $1.88 Analyst target: $10.00 Upside: 431.91%
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.